Scilex Holding Company (SCLX) vs Sanofi (SNY)
- Scilex Holding Company SCLX 2.83 +0.35%
- Sanofi SNY 40.61 +0.79%
Scilex Holding Company and Sanofi are both Drug Manufacturers General companies. Sanofi is the larger, with a market value of $96.0B against $19.8M — 4840.2× the size. Scilex Holding Company has negative trailing earnings, so its P/E is not meaningful; Sanofi trades at 21.3×. Sanofi grew revenue faster over the last twelve months: 21.3% against −28.6%. Sanofi has the higher net margin (8.22% vs −1,418.5%) and the higher return on invested capital (6.58% vs 0.00%). Across the 18 metrics below, Sanofi leads on 12 and Scilex Holding Company on 6.
Valuation
Profitability
| Metric | SCLX | SNY | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 55.50% | 72.78% | 72.77% |
| Operating margin | (1,136.40%) | 18.24% | 18.77% |
| Net margin | (1,418.45%) | 8.22% | 8.27% |
| Free cash flow margin | (56.37%) | 25.53% | 17.18% |
| Return on equity | 160.27% | 5.87% | 5.87% |
| Return on assets | (265.83%) | 3.21% | 2.57% |
| Return on invested capital | 0.00% | 6.58% | 6.11% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack